CLPT — Clearpoint Neuro Cashflow Statement
0.000.00%
Last trade - 00:00
- $144.28m
- $131.09m
- $23.96m
- 43
- 10
- 53
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -5.54 | -6.78 | -14.4 | -16.4 | -22.1 |
Depreciation | |||||
Non-Cash Items | 1.64 | 1.3 | 3.24 | 4.31 | 8.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.911 | -2.66 | -1.68 | -4.29 | -0.356 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.85 | -7.81 | -12.7 | -16.2 | -13.7 |
Capital Expenditures | -0.16 | -0.482 | -0.168 | -1.15 | -1.05 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | -9.59 | 10 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.16 | -0.482 | -0.168 | -10.7 | 8.95 |
Financing Cash Flow Items | -0.075 | — | -0.599 | -0.336 | -0.21 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.6 | 22.7 | 46.9 | 0.409 | 0.296 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.59 | 14.4 | 34 | -26.5 | -4.47 |